CX Institutional’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-1,221
| Closed | -$20K | – | 1727 |
|
|
2026
Q2 | $20K | Sell |
1,221
-1,862
| -60% | -$30.7K | ﹤0.01% | 1178 |
|
|
2026
Q1 | $50K | Sell |
3,083
-1,406
| -31% | -$22K | ﹤0.01% | 974 |
|
|
2025
Q4 | $67K | Sell |
4,489
-3,186
| -42% | -$45K | ﹤0.01% | 923 |
|
|
2025
Q3 | $99K | Sell |
7,675
-87,668
| -92% | -$1.17M | ﹤0.01% | 822 |
|
|
2025
Q2 | $1.45M | Buy |
95,343
+47,515
| +99% | +$741K | 0.05% | 223 |
|
|
2025
Q1 | $799K | Buy |
47,828
+9,924
| +26% | +$183K | 0.03% | 304 |
|
|
2024
Q4 | $714K | Sell |
37,904
-26,724
| -41% | -$515K | 0.03% | 296 |
|
|
2024
Q3 | $1.21M | Sell |
64,628
-225,649
| -78% | -$4.32M | 0.05% | 259 |
|
|
2024
Q2 | $5.48M | Sell |
290,277
-23,149
| -7% | -$395K | 0.26% | 97 |
|
|
2024
Q1 | $5.09M | Buy |
+313,426
| New | +$4.59M | 0.25% | 97 |
|
|
2019
Q3 | – | Sell |
-82
| Closed | -$1K | – | 929 |
|
|
2019
Q2 | $1K | Buy |
+82
| New | +$648 | ﹤0.01% | 900 |
|
CX Institutional's SEM Position: Q3 2026 in Review
CX Institutional sold out of Select Medical (SEM) in Q3 2026, closing a stake of 1,221 shares — an estimated $20K sold.
CX Institutional first reported a position in SEM in Q2 2019 and held it in 11 quarters. The position peaked at $5.48M in Q2 2024. 0 funds tracked by Wall St. Rank hold SEM as of Q3 2026.
- CX Institutional reported no remaining Select Medical position as of Q3 2026 after selling out during the quarter.
- CX Institutional sold 1,221 Select Medical shares in Q3 2026, an estimated $20K.
- CX Institutional first reported a position in Select Medical in Q2 2019 and held it in 11 quarters.
- CX Institutional's Select Medical position peaked at $5.48M in Q2 2024.
- 0 funds tracked by Wall St. Rank held Select Medical as of Q3 2026.
Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.